THMO Key Statistics, Chart & Performance
The current stock price of THMO is 0.3102 USD. In the past month the price decreased by -40.41%. In the past year, price decreased by -76.85%.
THMO Latest News, Press Relases and Analysis
THMO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.14 | 218.15B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.81 | 200.88B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.26 | 145.47B | ||
| SYK | STRYKER CORP | 27.91 | 140.57B | ||
| IDXX | IDEXX LABORATORIES INC | 57.59 | 57.99B | ||
| BDX | BECTON DICKINSON AND CO | 13.35 | 55.18B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.85 | 49.00B | ||
| RMD | RESMED INC | 25.35 | 36.63B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.15 | 37.95B | ||
| DXCM | DEXCOM INC | 34.71 | 25.18B | ||
| PODD | INSULET CORP | 66.98 | 21.53B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.54 | 18.50B |
Related stock screener links
About THMO
Company Profile
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 40 full-time employees. The company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
Company Info
THERMOGENESIS HOLDINGS INC
2711 Citrus Rd
Rancho Cordova CALIFORNIA 95742 US
CEO: Chris Xu
Employees: 40
Phone: 19168585100
THERMOGENESIS HOLDINGS INC / THMO FAQ
What does THERMOGENESIS HOLDINGS INC do?
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 40 full-time employees. The company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
What is the stock price of THERMOGENESIS HOLDINGS INC today?
The current stock price of THMO is 0.3102 USD. The price decreased by -25.84% in the last trading session.
Does THMO stock pay dividends?
THMO does not pay a dividend.
What is the ChartMill technical and fundamental rating of THMO stock?
THMO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of THERMOGENESIS HOLDINGS INC (THMO) based on its PE ratio?
THERMOGENESIS HOLDINGS INC (THMO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.28).
Can you provide the number of employees for THERMOGENESIS HOLDINGS INC?
THERMOGENESIS HOLDINGS INC (THMO) currently has 40 employees.
Can you provide the upcoming earnings date for THERMOGENESIS HOLDINGS INC?
THERMOGENESIS HOLDINGS INC (THMO) will report earnings on 2024-08-08, after the market close.
THMO Technical Analysis
THMO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to THMO. Both the profitability and financial health of THMO have multiple concerns.
THMO Financial Highlights
Over the last trailing twelve months THMO reported a non-GAAP Earnings per Share(EPS) of -4.28. The EPS increased by 76.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -146.23% | ||
| ROE | -1512.82% | ||
| Debt/Equity | 4.31 |
THMO Forecast & Estimates
7 analysts have analysed THMO and the average price target is 5.1 USD. This implies a price increase of 1544.1% is expected in the next year compared to the current price of 0.3102.
For the next year, analysts expect an EPS growth of 102.13% and a revenue growth 48.46% for THMO